Zayani Y - Search Results

1

Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study.

Guizani I, Zidi W, Zayani Y, Nesrine F, Douik H, Sanhaji H, Mourali MS, Feki M, Allal-Elasmi M. Guizani I, et al. Among authors: zayani y. Mol Biol Rep. 2022 Oct;49(10):9171-9179. doi: 10.1007/s11033-022-07742-1. Epub 2022 Aug 12. Mol Biol Rep. 2022. PMID: 35960412

2

Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: a 5 years cohort study.

Guizani I, Zidi W, Zayani Y, Boudiche S, Hadj-Taieb S, Sanhaji H, Zaroui A, Mechmeche R, Mourali MS, Feki M, Allal-Elasmi M. Guizani I, et al. Among authors: zayani y. Mol Biol Rep. 2019 Oct;46(5):4699-4707. doi: 10.1007/s11033-019-04914-4. Epub 2019 Jun 19. Mol Biol Rep. 2019. PMID: 31218540

3

Matrix metalloproteinase-7 could be a predictor for acute inflammation in psoriatic patients.

Abbes A, Zayani Y, Zidi W, Hammami MB, Mebazaa A, El Euch D, Ben Ammar A, Sanhaji H, El May MV, Mokni M, Feki M, Allal-Elasmi M. Abbes A, et al. Among authors: zayani y. Cytokine. 2020 Oct;134:155195. doi: 10.1016/j.cyto.2020.155195. Epub 2020 Jul 11. Cytokine. 2020. PMID: 32663776

4

Abnormal circulating levels of matrix metalloproteinases and their inhibitors in diabetes mellitus.

Zayani Y, Allal-Elasmi M, Jacob MP, Zidi W, Ftouhi B, Feki M, Slimane H, Kaabachi N. Zayani Y, et al. Clin Lab. 2012;58(7-8):779-85. Clin Lab. 2012. PMID: 22997979

5

Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.

Zayani Y, Allal-Elasmi M, Jacob MP, Zidi W, Zaroui A, Feki M, Mourali S, Mechmech R, Kaabachi N. Zayani Y, et al. Clin Lab. 2013;59(1-2):169-75. doi: 10.7754/clin.lab.2012.120223. Clin Lab. 2013. PMID: 23505923

6

Psoriasis is associated with increased Framingham ten-year risk score for coronary heart disease in Tunisians.

Allal-El Asmi M, Mebazaa A, Zidi W, Zayani Y, Feki M, Mokni M, Ben Osman A, Kaabachi N. Allal-El Asmi M, et al. Among authors: zayani y. Clin Lab. 2013;59(11-12):1247-52. doi: 10.7754/clin.lab.2013.121009. Clin Lab. 2013. PMID: 24409658

7

The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome.

Allal-Elasmi M, Zayani Y, Zidi W, Zaroui A, Feki M, Mourali S, Mechmeche R, Kaabachi N. Allal-Elasmi M, et al. Among authors: zayani y. Clin Lab. 2014;60(6):951-6. doi: 10.7754/clin.lab.2013.130346. Clin Lab. 2014. PMID: 25016699

8

Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients.

Zayani Y, El Golli N, Zidi W, Guizani I, Boussairi S, Aloui S, Ayadi I, Ftouhi B, Feki M, Ben Romdhane N, Ben Sliman H, Allal-Elasmi M, Kaabachi N. Zayani Y, et al. Cytokine. 2016 Oct;86:47-52. doi: 10.1016/j.cyto.2016.07.009. Epub 2016 Jul 25. Cytokine. 2016. PMID: 27455450

9

Metabolic Syndrome, Independent Predictor for Coronary Artery Disease.

Zidi W, Allal-Elasmi M, Zayani Y, Zaroui A, Guizani I, Feki M, Mourali MS, Mechmeche R, Kaabachi N. Zidi W, et al. Among authors: zayani y. Clin Lab. 2015;61(10):1545-52. doi: 10.7754/clin.lab.2015.150219. Clin Lab. 2015. PMID: 26642718

10

Abnormal Circulating Levels of Metalloproteinase and Their Inhibitor in Hypertensive Patients.

Zayani Y, Allal-Elasmi M, Zidi W, Guizani I, Jacob MP, Feki M, Kaabachi N. Zayani Y, et al. Clin Lab. 2016;62(4):527-33. doi: 10.7754/clin.lab.2015.150633. Clin Lab. 2016. PMID: 27215070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters